Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot

AstraZenecas (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and…

Fact Check-Chimpanzee adenovirus vector in the AstraZeneca COVID-19 vaccine does not cause monkeypox

...By Reuters Fact Check False claims that the outbreak of monkeypox... Reuters via email: “The virus used in the AZ vaccine…

Samsung Biologics, AstraZeneca shutting down their joint venture Archigen Biotech

Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, is shutting down its joint venture with multinational pharmaceutical…

AstraZeneca, Eli Lilly in focus as U.S. panel weighs routine kidney disease screening

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share

AstraZeneca: EU Approves Covid-19 Vaccine Vaxzevria As Third Dose Booster

LONDON (dpa-AFX) - British drug major AstraZeneca PLC (AZN.L, AZN) announced Monday that its COVID-19 vaccine, Vaxzevria, has been granted…

TOP NEWS: AstraZeneca Covid vaccine wins booster jab approval in EU

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-AstraZeneca says EU regulator approves COVID shot as booster

...(Adds details from statement, background) May 23 (Reuters......…

AstraZeneca says COVID shot approved in EU as booster

...(Reuters) - Drugmaker AstraZeneca on Monday its COVID-19 vaccine......…

Form 6-K ASTRAZENECA PLC For: May 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earlier this May, Attana participated at the conference Advances In Cell-Based Screening In Drug Discovery 2022

The fourth edition of the conference was held at Astra Zenecas R&D site in Gothenburg on May 10–12. Attana participated…

UPDATE 1-EU health regulator backs using AstraZeneca COVID shot as booster

...(Adds detail, background) By Natalie Grover LONDON, May 19 (Reuters......…

AstraZeneca Buy

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 11500…

AstraZeneca: Downgrade

Frankfurt (www.aktiencheck.de) - Rating-Update: David Evans, Analyst von Kepler Cheuvreux, stuft die Aktie des Pharmakonzerns AstraZeneca plc (ISIN: GB0009895292, WKN:…

AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies

AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus....…

If stagflation emerges, buy AstraZeneca and Reckitt, avoid Aviva and BP says analyst

Um den gesamten Artikel unter proactiveinvestors.com zu lesen, klicken Sie bitte auf die Überschrift...…

Proteros expands oncology collaboration with AstrZeneca

This multi-year deal builds on the ongoing collaboration with AstraZeneca announced in June last year, to include the development of…

AstraZeneca strengthens COVID portfolio via license deal with RQ Biotechnology for monoclonal antibodies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TOP NEWS: AstraZeneca wins license to make and sell Covid antibodies

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-AstraZeneca bolsters COVID therapeutics with RQ Bio deal

...(Adds detail) LONDON, May 17 (Reuters) - AstraZeneca is paying up......…

AstraZeneca wades deeper into COVID therapeutics

...LONDON (Reuters) - AstraZeneca has signed a licence agreement......…

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

AstraZeneca granted exclusive worldwide licence to develop, manufacture and commercialise RQ Bios existing early-stage monoclonal antibodies (mAbs) against SARS-CoV-2 and…

BenevolentAI Says Achieves Third Milestone In AI-enabled Drug Discovery Collaboration With AstraZeneca

LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) has selected an additional novel target for idiopathic pulmonary fibrosis for its drug…

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAIs drug discovery platform and selected for AstraZenecas drug development…

Netscientific hails work of ProAxsis business on AstraZeneca Covid antibody test

Um den gesamten Artikel unter proactiveinvestors.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

NetScientific Shares Rise on Successful Completion of AstraZeneca Covid-19 Antibody Test

NetScientific Shares Rise on Successful Completion of AstraZeneca Covid-19 Antibody Test...…

AstraZeneca: Phase III Trial Shows PT027 Reduces Risk Of Severe Exacerbation By 27% In Asthma Patients

LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) said MANDALA Phase III trial results showed that PT027 (albuterol/budesonide) at two different…

Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer

CHENGDU, China and SEATTLE and LONDON, May 13, 2022 /PRNewswire/ -- BAILI-BIOPHARMACEUTICAL CO., LTD. ("Baili") and its wholly owned subsidiary,…

Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV

Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus…

Insights on the Opioids Global Market to 2030 - Featuring Purdue Pharma, AstraZeneca and Sanofi Among Others

DUBLIN, May 6, 2022 /PRNewswire/ -- The "Opioids Market by Product Type and Application: Global Opportunity Analysis and Industry Forecast,…

Form 6-K ASTRAZENECA PLC For: May 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Farxiga cuts risk of death/heart failure in certain patients in late-stage study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K ASTRAZENECA PLC For: May 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca says Ultomiris met main goal in late-stage study for rare autoimmune disorder

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca autoimmune treatment meets trial endpoint

Um den gesamten Artikel unter sharecast.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: Phase III Trial Of Farxiga Effective In Treating Heart Failure Regardless Of Ejection Fraction

LONDON (dpa-AFX) - AstraZeneca Plc (AZN, AZN.L) said the DELIVER Phase III trial results showed its Farxiga or dapagliflozin reached…

AstraZeneca: Phase III Trial Of Ultomiris Meets Main Goal In Neuromyelitis Optica Spectrum Disorder

LONDON (dpa-AFX) - AstraZeneca Plc (AZN, AZN.L) said phase III CHAMPION-NMOSD trial results showed that Ultomiris or ravulizumab-cwvz achieved a…

AstraZeneca Says Farxiga Heart Treatment Phase 3 Trial Met Primary Endpoint

AstraZeneca Says Farxiga Heart Treatment Phase 3 Trial Met Primary Endpoint...…

AstraZeneca Says Autoimmune Disease Treatment Ultomiris Met Phase 3 Trial Primary Endpoint

AstraZeneca Says Autoimmune Disease Treatment Ultomiris Met Phase 3 Trial Primary Endpoint...…

Outlook on the Smart Inhalers Global Market to 2030 - Featuring Aptar Group, AstraZeneca and Cognita Labs Among Others

DUBLIN, May 4, 2022 /PRNewswire/ -- The "Smart Inhalers Market by Product, Indication, and Distribution Channel: Global Opportunity Analysis and…

Form 6-K ASTRAZENECA PLC For: May 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: Imfinzi Plus Chemotherapy Granted Priority Review In U.S. For Metastatic Biliary Tract Cancer

LONDON (dpa-AFX) - AstraZeneca Plc.s (AZN.L, AZN) supplemental Biologics License Application or sBLA for Imfinzi or durvalumab, in combination with…

Former AstraZeneca oncology head to help All Blue in Zymeworks takeover bid

...(Reuters) - Investment firm All Blue Capital would be advised... to a press statement seen by…

Total Voting Rights

3 May 2022 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca Buy

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca nach Zahlen auf "Buy" mit einem Kursziel von…

AstraZeneca Outperform

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Bank Credit Suisse hat die Einstufung für Astrazeneca nach einem soliden ersten Quartal auf…

InDex Pharmaceuticals strengthens the organization with Eva Arlander as Chief Development Officer and announces changes in the composition of the management team

May 2, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that the company has appointed Eva Arlander as Chief…